← Back to all articles
Clinical TrialsPubMed Verified

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study

Sanches RF, de Lima Osorio F, dos Santos RG, Macedo LR, Maia-de-Oliveira JP, Wichert-Ana L, de Araujo DB, Riba J, Crippa JA, Hallak JE

Journal of Clinical Psychopharmacology (2016)

Open-label trial
Abstract

SPECT neuroimaging study in 17 patients with recurrent depression. Ayahuasca increased blood flow in mood-regulating regions including nucleus accumbens, insula, and subgenual area.

Participants17
Citations230
Study TypeOpen-label trial
depressionSPECTneuroimagingcerebral blood flow
DOI: 10.1097/JCP.0000000000000436View on PubMed

Related Articles

Clinical Trials

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report

Osorio FL, Sanches RF et al.

Revista Brasileira de Psiquiatria, 2015
Clinical Trials

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial

Palhano-Fontes F, Barreto D et al.

Psychological Medicine, 2019
Clinical Trials

Effects of ayahuasca on the recognition of facial expressions of emotions in naive healthy volunteers: a pilot, proof-of-concept, randomized controlled trial

Rocha JM, Rossi GN et al.

Journal of Clinical Psychopharmacology, 2021
Clinical Trials

Ayahuasca improves self-perception of speech performance in subjects with social anxiety disorder: a pilot, proof-of-concept, randomized, placebo-controlled trial

Dos Santos RG, Osorio FL et al.

Journal of Clinical Psychopharmacology, 2021